Markets are navigating a tricky backdrop today. Iran war fears are weighing on sentiment in Europe and Asia. Oil prices remain elevated. That is feeding inflation worries and pushing gold toward a weekly loss. The yen jumped as Japan threatened further intervention. European stocks edged higher in Friday's session despite the geopolitical noise.
Over 1,500 companies report this week. Cisco Systems is the headline act, with its Q3 2026 earnings call set for Wednesday, May 13. At ~$364B market cap, it is the biggest tech name in the earnings queue. Investors will focus on AI infrastructure demand signals. SoftBank Group also reports Wednesday — its Vision Fund AI bets make it a key read on sentiment in the sector. Elsewhere, Cigna beat Q1 expectations today and raised full-year EPS guidance. The health insurer's strong print adds to a broadly solid earnings season so far.
Wolfspeed remains one of the most extreme short setups in the market. SI now sits at 60.4% of free float. Availability is zero. New short positions are almost impossible to open. Bears are fully committed but cannot add more. At the micro-cap end, Biodexa Pharmaceuticals is running at an extraordinary 1,771% SI of free float. Cost to borrow hit 503%. Extreme volatility is the only certainty here.
Insider filings tell a cautious story at the top. Quanta Services CEO Earl Austin filed $61M in sales on May 7. FTAI Aviation director Martin Tuchman filed $51M in sales in early May. Comfort Systems CEO Brian Lane sold $22M on May 6. Against that, Bill Ackman bought $15.7M in Pershing Square shares — a notable vote of confidence in his own vehicle.
Akamai got a 26% analyst target price jump this week. EPAM Systems saw targets slashed nearly 12%. With SI at 15.6% of free float, EPAM bears are already positioned. Cisco's earnings Wednesday will set the tone for the broader tech read into next week.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
